Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > BROWSE ARTICLES > Author index
Search
Min Ju Kim  (Kim MJ) 1 Article
Obesity and Metabolism
Metformin-Associated Lactic Acidosis: Predisposing Factors and Outcome
Min Ju Kim, Ju Young Han, Jun Young Shin, Shin Il Kim, Jeong Min Lee, Seongbin Hong, So Hun Kim, Moon Suk Nam, Yong Seong Kim
Endocrinol Metab. 2015;30(1):78-83.   Published online March 27, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.1.78
  • 4,624 View
  • 79 Download
  • 28 Web of Science
  • 27 Crossref
AbstractAbstract PDFPubReader   
Background

Metformin is considered the first choice oral treatment for type 2 diabetes patients in the absence of contraindications. Rarely, life-threatening complications associated with metformin treatment are seen in some patients with underlying diseases. The aim of this study was to further investigate the clinical profiles and risk factors for metformin-associated lactic acidosis (MALA) and the treatment modalities according to survival.

Methods

To identify MALA, we performed a retrospective study in seven diabetic patients who were taking metformin and had been diagnosed with lactic acidosis at Inha University Hospital between 1995 and 2012. For each patient, we recorded the age, sex, daily metformin dosage, laboratory test results, admission diagnosis, and risk factors. Also, concurrent conditions, treatment modalities, and outcomes were evaluated.

Results

Six patients had risk factors for lactic acidosis before admission. All patients had renal impairment on admission as a precipitating risk factor. Five patients survived and two patients died despite early renal replacement therapy. Older patients tended to have a poorer prognosis.

Conclusion

Renal function must be monitored in elderly type 2 diabetes mellitus patients with underlying diseases and conditions causing renal impairment who begin metformin treatment. Accurate recognition of MALA and initiation of renal replacement are essential for treatment.

Citations

Citations to this article as recorded by  
  • An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center Network From 2011 to 2021
    Shawn M. Varney, Sarah Watkins, Haylea Stuteville, Mark L. Winter, Han Tony Gao, Thomas G. Martin, Ryan P. Morrissey, Wayne R. Snodgrass, Brett A. Roth
    Hospital Pharmacy.2024;[Epub]     CrossRef
  • Metformin Treatment Reduces the Incidence of Rheumatoid Arthritis: A Two-Sample Mendelian Randomized Study
    Jialin Liang, Yuanqing Cai, Jianan Zhang, Zhaopu Jing, Leifeng Lv, Guangyang Zhang, Rupeng Zhang, Ruiyu Liu, Kai Nan, Xiaoqian Dang
    Journal of Clinical Medicine.2023; 12(7): 2461.     CrossRef
  • PLGA-based microspheres loaded with metformin hydrochloride: Modified double emulsion method preparation, optimization, characterization, and in vitro evaluation
    Priyanka Chauhan, Himanshu Paliwal, Chetan Singh Chauhan, Ankit Paliwal
    Annales Pharmaceutiques Françaises.2023; 81(6): 997.     CrossRef
  • Metformin-associated lactic acidosis: underlying multiple myeloma
    Clara GOMES, Ana FERREIRA, Neuza SOARES, Vanessa CHAVES, Luís LEMOS, Sofia TAVARES, Marta COUTO
    Gazzetta Medica Italiana Archivio per le Scienze Mediche.2022;[Epub]     CrossRef
  • Metformin-associated lactic acidosis and factors associated with 30-day mortality
    Kanin Thammavaranucupt, Boonchan Phonyangnok, Watanyu Parapiboon, Laddaporn Wongluechai, Watthikorn Pichitporn, Jirut Sumrittivanicha, Somnuek Sungkanuparph, Arkom Nongnuch, Kulapong Jayanama, Donovan Anthony McGrowder
    PLOS ONE.2022; 17(8): e0273678.     CrossRef
  • Metformin Associated Lactic Acidosis in Clinical Practice – A Case Series
    Philipp Schädle, Otto Tschritter, Monika Kellerer
    Experimental and Clinical Endocrinology & Diabetes.2021; 129(11): 842.     CrossRef
  • Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
    Qi Yu, Jia-Jia Zhu, Wen-Xian Liu
    BMC Cardiovascular Disorders.2020;[Epub]     CrossRef
  • Metformin: current clinical applications in nondiabetic patients with cancer
    Kailin Chen, Yajun Li, Zhen Guo, Yong Zeng, Wei Zhang, Hui Wang
    Aging.2020; 12(4): 3993.     CrossRef
  • Specifics of diabetes in old age
    Markéta Kubíčková
    Interní medicína pro praxi.2019; 21(4): 223.     CrossRef
  • The Association between Metformin Therapy and Lactic Acidosis
    Isabelle H. S. Kuan, Ruth L. Savage, Stephen B. Duffull, Robert J. Walker, Daniel F. B. Wright
    Drug Safety.2019; 42(12): 1449.     CrossRef
  • Metformin overdose: A serious iatrogenic complication—Western France Poison Control Centre Data Analysis
    Alexandre Stevens, Jean‐François Hamel, Ali Toure, Samy Hadjadj, David Boels
    Basic & Clinical Pharmacology & Toxicology.2019; 125(5): 466.     CrossRef
  • Risk of Metformin-Associated Lactic Acidosis (MALA) in Patients After Gastric Bypass Surgery
    Laura N. Deden, Edo O. Aarts, Stephanie C. W. Aelfers, Marcel M. G. J. van Borren, Ignace M. C. Janssen, Frits J. Berends, Hans de Boer
    Obesity Surgery.2018; 28(4): 1080.     CrossRef
  • Metformin-related lactic acidosis: Case report
    Jesús Salvador Sánchez-Díaz, Enrique Monares-Zepeda, Enrique Antonio Martínez-Rodríguez, Jorge Samuel Cortés-Román, Oscar Torres-Aguilar, Karla Gabriela Peniche-Moguel, Susana Patricia Díaz-Gutiérrez, Eusebio Pin-Gutiérrez, Gerardo Rivera-Solís, Rosalba C
    Colombian Journal of Anesthesiology.2017; 45(4): 353.     CrossRef
  • Metformin-related lactic acidosis: Case report☆
    Jesús Salvador Sánchez-Díaz, Enrique Monares-Zepeda, Enrique Antonio Martínez-Rodríguez, Jorge Samuel Cortés-Román, Oscar Torres-Aguilar, Karla Gabriela Peniche-Moguel, Susana Patricia Díaz-Gutiérrez, Eusebio Pin-Gutiérrez, Gerardo Rivera-Solís, Rosalba C
    Colombian Journal of Anesthesiology.2017; 45(4): 353.     CrossRef
  • Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes
    Eun Young Lee, Sena Hwang, Yong-ho Lee, Seo Hee Lee, Young Mi Lee, Hua Pyong Kang, Eugene Han, Woonhyoung Lee, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Yonsei Medical Journal.2017; 58(2): 312.     CrossRef
  • Hypoglycemia and severe lactic acidosis in a dog following metformin exposure
    Nicole Barrella, Beth Eisenberg, Stephanie Nicole Simpson
    Clinical Case Reports.2017; 5(12): 2097.     CrossRef
  • Acidosis láctica por metformina: reporte de caso
    Jesús Salvador Sánchez-Díaz, Enrique Monares-Zepeda, Enrique Antonio Martínez-Rodríguez, Jorge Samuel Cortés-Román, Oscar Torres-Aguilar, Karla Gabriela Peniche-Moguel, Susana Patricia Díaz-Gutiérrez, Eusebio Pin-Gutiérrez, Gerardo Rivera-Solís, Rosalba C
    Revista Colombiana de Anestesiología.2017; 45(4): 353.     CrossRef
  • Towards natural mimetics of metformin and rapamycin
    Alexander Aliper, Leslie Jellen, Franco Cortese, Artem Artemov, Darla Karpinsky-Semper, Alexey Moskalev, Andrew G. Swick, Alex Zhavoronkov
    Aging.2017; 9(11): 2245.     CrossRef
  • Metformin-Associated Lactic Acidosis
    Martin R. Hevesy
    Advanced Emergency Nursing Journal.2017; 39(1): 26.     CrossRef
  • Metformin associated lactic acidosis (MALA): clinical profiling and management
    Alessandra Moioli, Barbara Maresca, Andrea Manzione, Antonello Maria Napoletano, Daniela Coclite, Nicola Pirozzi, Giorgio Punzo, Paolo Menè
    Journal of Nephrology.2016; 29(6): 783.     CrossRef
  • Risk assessment and management of post-transplant diabetes mellitus
    Eugene Han, Myoung Soo Kim, Yu Seun Kim, Eun Seok Kang
    Metabolism.2016; 65(10): 1559.     CrossRef
  • Temporal trends in the use of antidiabetic medicines: a nationwide 9-year study in older people living in New Zealand
    Prasad S. Nishtala, Mohammed Saji Salahudeen
    Therapeutic Advances in Drug Safety.2016; 7(5): 184.     CrossRef
  • Metformin-associated lactic acidosis: Current perspectives on causes and risk
    Ralph DeFronzo, G. Alexander Fleming, Kim Chen, Thomas A. Bicsak
    Metabolism.2016; 65(2): 20.     CrossRef
  • Lactic acidosis and the relationship with metformin usage
    Weiyi Huang, Ronald L. Castelino, Gregory M. Peterson
    Medicine.2016; 95(46): e4998.     CrossRef
  • Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states
    Hye Suk Kang, Ho-Chan Cho, Jae-Ho Lee, Goo Taeg Oh, Seung-Hoi Koo, Byung-Hyun Park, In-Kyu Lee, Hueng-Sik Choi, Dae-Kyu Song, Seung-Soon Im
    Scientific Reports.2016;[Epub]     CrossRef
  • Metformin-associated lactic acidosis: time to let it go?
    Chantal Mathieu
    Journal of Diabetes and its Complications.2015; 29(8): 974.     CrossRef
  • Metformin: risk-benefit profile with a focus on cancer
    Nicoletta Provinciali, Matteo Lazzeroni, Massimiliano Cazzaniga, Franco Gorlero, Barbara K Dunn, Andrea DeCensi
    Expert Opinion on Drug Safety.2015; 14(10): 1573.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism